SOPHIA GENETICS SA

Consensus SOPHiA GENETICS SA Börse Stuttgart

Stocks

90B

CH1125843347

Advanced Medical Equipment & Technology

Real-time Estimate Tradegate 06:20:32 2026-09-15 EDT			5-day change	1st Jan Change
6.800 ^EUR	0.00%		-5.63%	+72.68%

08-04	SOPHiA GENETICS SA, Q2 2026 Earnings Call, Aug 04, 2026
08-04	Sophia Genetics SA and AstraZeneca Enter Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies	CI

Evolution of the Average Target: SOPHiA GENETICS SA

Data source: SOPHiA GENETICS SA(SOPH)

Evolution of the Target Price: SOPHiA GENETICS SA

Data source: SOPHiA GENETICS SA(SOPH)

Changes in Analyst Recommendations: SOPHiA GENETICS SA

Data source: SOPHiA GENETICS SA(SOPH)

4.INTQt_pqxQHXlQMJitITJ6hd7n0Cn8NwPSn5t4DYZtU.YqWngdcF83eW70Vxp59eZd8Iry5Krbo7Xl2jztmQIOcYhoGFywy2SOH-dA~c97e15b00e15c737af39782066d8547b

Analysts' recommendations: SOPHiA GENETICS SA

07-20	HC Wainwright Initiates SOPHiA GENETICS at Buy With $12 Price Target	MT
24-08-07	Morgan Stanley Downgrades SOPHiA GENETICS to Equal Weight From Overweight, Adjusts Price Target to $5 From $10	MT
24-08-06	Top Midday Decliners	MT
24-06-27	Guggenheim Initiates SOPHiA GENETICS at Buy With $6 Price Target	MT
23-11-29	RBC Initiates SOPHiA GENETICS at Outperform With $8 Price Target, Notes 'Attractive' Entry Point, Exposure to Long-Term Growth in Sequencing, Life Science Research	MT
23-05-10	Credit Suisse Raises SOPHiA GENETICS' Price Target to $5 From $2.25 After 'Solid' Q1 Results, Keeps Neutral Rating	MT
23-05-10	Morgan Stanley Trims Price Target on Sophia Genetics to $10 From $11, Maintains Overweight Rating	MT
23-03-08	Morgan Stanley Adjusts Price Target on SOPHiA GENETICS to $11 From $12, Maintains Overweight Rating	MT
23-01-03	BTIG Starts SOPHiA GENETICS at Buy With $6 Price Target	MT
22-11-23	Credit Suisse Starts SOPHiA GENETICS at Neutral With $2 Price Target	MT
22-11-09	Morgan Stanley Adjusts Price Target on SOPHiA GENETICS to $12 From $13, Maintains Overweight Rating	MT
22-03-16	JPMorgan Lowers Price Target for SOPHiA GENETICS SA to $18 From $23, Maintains Overweight Rating	MT
22-03-16	Morgan Stanley Adjusts SOPHiA GENETICS' Price Target to $17 from $18, Keeps Overweight Rating	MT
22-02-15	Morgan Stanley Adjusts SOPHiA GENETICS Price Target to $18 From $23, Maintains Overweight Rating	MT
21-08-17	SOPHiA GENETICS : Credit Suisse Starts SOPHiA GENETICS at Outperform with $22 Price Target	MT
21-08-17	SOPHiA GENETICS : Morgan Stanley Starts SOPHiA GENETICS at Overweight With $24 Price Target	MT
21-08-17	SOPHiA GENETICS : JPMorgan Starts SOPHiA GENETICS at Overweight With $23 Price Target	MT
21-08-17	SOPHiA GENETICS : Cowen Initiates Coverage on SOPHiA GENETICS SA With Outperform Rating	MT

More recommendations

Medical Software & Technology Services

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	VEEVA SYSTEMS INC.					+11.9%
	PRO MEDICUS LIMITED					+22.41%
	SECTRA AB					+15.72%
	HEARTFLOW, INC.					-9.61%
	GENERATE BIOMEDICINES, INC.					+68.75%
	OMNICELL, INC.					+72.66%
	XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.			-		+60.66%
	ARBUTUS BIOPHARMA CORPORATION			-	-	+7.21%
	Average					+31.21%
	Weighted average by Cap.					+16.32%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

5

Last Close Price

7.860USD

Average target price

9.750USD

Spread / Average Target

+24.05%

High Price Target

14.00USD

Spread / Highest target

+78.12%

Low Price Target

7.000USD

Spread / Lowest Target

-10.94%

Analyst Consensus Detail

Consensus revision (last 18 months)

Ratings

Trader

Investor

-

Global

-

Quality

-

ESG MSCI

-

Stock Market
Stocks
SOPH Stock
90B Stock
Consensus SOPHiA GENETICS SA

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!